¼¼°èÀÇ ½ÉÇ÷°ü ÁßÀç½Ã¼ú ¹× ¸»ÃÊÇ÷°ü ±â±â ½ÃÀå : Á¦Ç° À¯Çüº°, ÀûÀÀÁõº°, ¿¬·ÉÃþº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)
Interventional Cardiology and Peripheral Vascular Devices Market by Product Type, Indication, Age Group, End User, and Region 2025-2033
»óǰÄÚµå : 1675293
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 145 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,339,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,786,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,233,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½ÉÇ÷°ü ÁßÀç½Ã¼ú ¹× ¸»ÃÊÇ÷°ü ±â±â ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 267¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö ½ÃÀå ±Ô¸ð°¡ 494¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025-2033³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 6.72%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î Àü¸ÁÇϰí ÀÖ½À´Ï´Ù. ¸¸¼º ½ÉÀ庴 ȯÀÚ Áõ°¡, ¸»Ãʵ¿¸ÆÁúȯ(PAD) ±ÞÁõ, ÃÖ¼Òħ½À(MI) ½Ã¼ú¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼±È£µµ Áõ°¡ µîÀÌ ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

½ÉÇ÷°ü ÁßÀç½Ã¼ú(Interventional Cardiology)Àº ´Ù¼öÀÇ ÆÇ¸·Áõ, °ü»óµ¿¸Æ, ¼±Ãµ¼º ½ÉÀåÁúȯÀ» Ä¡·áÇϱâ À§ÇØ Åõ½Ã°æÀ» ÀÌ¿ëÇÑ Ç÷°ü ³» Ä«Å×ÅÍ¿¡ ±â¹ÝÇÑ ½Ã¼ú¿¡ ÀÇÁ¸ÇÏ´Â ¼øÈ¯±âÇÐÀÇ ÇÏÀ§ Àü¹®ºÐ¾ß¸¦ ¸»ÇÕ´Ï´Ù. ÇÑÆí, ¸»ÃÊÇ÷°üÀåÄ¡´Â ƯÈ÷ ¸»ÃÊÇ÷°ü°èÀÇ µ¿¸Æ ¸·ÈûÀ̳ª Ç÷°ü ÇùÂøÀ» Ä¡·áÇϱâ À§ÇØ »ç¿ëµÇ´Â ÀÇ·á±â±â·Î, ±× °á°ú ½Åü °¢ ºÎÀ§·ÎÀÇ Ç÷·ù°¡ °¨¼ÒÇÏ°Ô µË´Ï´Ù. ÀÌ·¯ÇÑ ÁßÀçÀû ¹æ¹ýÀº ¼øÈ¯°è¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ½ÉÀå Áúȯ ¹× ¸»ÃÊ Ç÷°ü ÁúȯÀ» °ü¸®Çϰí, ÇÕº´Áõ°ú ÈäÅ͸¦ ÇÇÇϰí, ÅëÁõÀ» ÃÖ¼ÒÈ­Çϰí, ȸº¹À» ºü¸£°Ô Çϱâ À§ÇØ ÀϹÝÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ±× °á°ú, ½ÉÇ÷°ü ÁßÀç½Ã¼ú ¹× ¸»ÃÊÇ÷°ü ÀåÄ¡´Â ´Ù¾çÇÑ ±¸Á¶Àû ½ÉÀå Áúȯ ¹× µ¿¸Æ °ü·Ã ÁúȯÀÇ Ä¡·á, ±×¸®°í ¸»ÃÊÇ÷°ü ³» Ä¡·á ¹× °ü»óµ¿¸Æ Ä¡·á¿¡ ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ°í ÀÖ½À´Ï´Ù.

½ÉÇ÷°ü ÁßÀç½Ã¼ú ¹× ¸»ÃÊÇ÷°ü¿ë ÀÇ·á±â±â ½ÃÀå µ¿Çâ :

°ü»óµ¿¸ÆÁúȯ(CAD)°ú °°Àº ¸¸¼º ½ÉÀåÁúȯÀ» ¾Î°í ÀÖ´Â »ç¶÷µéÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Ä¡¸íÀûÀÎ °á°ú¸¦ ¿¹¹æÇϱâ À§ÇÑ Á¶±â ¹ß°ß ¹× °³ÀÔÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ¸»Ãʵ¿¸ÆÁúȯ(PAD)ÀÇ ¹ßº´·ü Áõ°¡¿Í ÇÔ²² ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ¿Í ÀÇ·á Àü¹®°¡µé »çÀÌ¿¡¼­ ±âÁ¸ ¼ö¼ú¿¡¼­ ÃÖ¼Òħ½À(MI) ¼ö¼ú·ÎÀÇ ÀüȯÀÌ »ó´çÈ÷ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ÃÖ¼Ò Ä§½À ¼ö¼úÀº Àý°³Ã¢ÀÌ ÀÛ°í, ¼ö¼ú·Î ÀÎÇÑ ÅëÁõ, ¼Õ»ó, ÈäÅͰ¡ Àû°í, ÀÔ¿ø ±â°£ÀÌ Âª°í, Á¤È®µµ°¡ ³ôÀ¸¸ç, ȸº¹ÀÌ ºü¸£±â ¶§¹®ÀÔ´Ï´Ù. ÀÌ¿¡ µû¶ó ³ë·ÉÀα¸ÀÇ È®´ë°¡ Àü ¼¼°è ½ÉÀå ¹× Ç÷°ü ÁúȯÀÇ ºÎ´ã Áõ°¡¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, ÀÌ´Â Á¦Ç° ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±Þ¼ÓÇÑ ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ ÁÖ¿ä Á¦Á¶¾÷üµéÀº ´õ ³ªÀº Ä¡·á °á°ú¸¦ ¾ò±â À§ÇØ ½ÉÇ÷°ü ÁßÀç½Ã¼ú ¹× ¸»ÃÊÇ÷°ü ±â±âÀÇ »õ·Ó°í Çõ½ÅÀûÀÎ º¯ÇüÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²², ÁÖ¿ä Á¦Á¶¾÷üµéÀÇ Áö¼ÓÀûÀÎ Á¦Ç° Ãâ½Ã¿Í Á¦Ç° ½ÂÀÎ °Ç¼ö Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¿Ü¿¡µµ »ýü Èí¼ö¼º ½ºÅÙÆ® µµÀÔ, ÀÀ±Þ ¹× ÁßÁõ ȯÀÚ ¼ö Áõ°¡, À¯¸®ÇÑ »óȯ Á¤Ã¥, ÀÇ·á ÀÎÇÁ¶ó °³¼±, Áö¼ÓÀûÀÎ R&D Ȱµ¿ µîµµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ ½ÉÇ÷°ü ÁßÀç½Ã¼ú ¹× ¸»ÃÊÇ÷°ü ±â±â ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°

Á¦7Àå ½ÃÀå ºÐ¼® : ÀûÀÀÁõº°

Á¦8Àå ½ÃÀå ºÐ¼® : ¿¬·ÉÃþº°

Á¦9Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦11Àå ¼ºÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎ, ±âȸ

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå PorterÀÇ Five Forces ºÐ¼®

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global interventional cardiology and peripheral vascular devices market size reached USD 26.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 49.4 Billion by 2033, exhibiting a growth rate (CAGR) of 6.72% during 2025-2033. The increasing number of individuals suffering from chronic heart conditions, surging incidences of peripheral arterial disease (PAD), and rising consumer preferences for minimally invasive (MI) procedures represent some of the key factors driving the market.

Interventional cardiology refers to the sub-specialty of cardiology that relies on intravascular catheter-based techniques with fluoroscopy to treat numerous valvular, coronary artery, and congenital heart diseases. On the other hand, peripheral vascular devices are medical devices used for treating artery blockages and narrowing of blood vessels, especially in the peripheral vasculature, resulting in reduced blood flow to different body parts. These interventional methods are commonly employed for managing cardiology diseases and peripheral vascular disorders affecting the circulatory system to avoid complications and scars while minimizing pain and promoting faster recovery. As a result, interventional cardiology and peripheral vascular devices find extensive applications in the treatment of various structural heart diseases and artery-related ailments, as well as in peripheral endovascular and coronary procedures.

Interventional Cardiology and Peripheral Vascular Devices Market Trends:

The increasing number of individuals suffering from chronic heart conditions, such as coronary artery diseases (CADs), has strengthened the need for early detection and intervention to prevent fatal consequences. This, coupled with the rising incidences of peripheral arterial disease (PAD), represents the primary factor driving the market growth. Additionally, there has been a substantial shift from traditional surgeries toward minimally invasive (MI) procedures among patients and healthcare professionals as they involve smaller incisions, less surgical pain, injury, and scarring, shorter hospital stays, higher accuracy, and quick recovery. In line with this, the expanding geriatric population is contributing to the growing burden of cardiological and vascular diseases across the globe, which in turn has augmented the product demand. Furthermore, due to rapid technological advancements, the leading manufacturers are developing new and innovative variants of interventional cardiology and peripheral vascular devices for better treatment outcomes. Along with this, continuous product launches by key players and the increasing number of product approvals have propelled market growth. Other factors, including the introduction of bio-absorbable stents, rising admission cases in emergency and critical care, favorable reimbursement policies, improving healthcare infrastructure, and ongoing research and development (R&D) activities, are also providing a positive thrust to the market growth.

Key Market Segmentation:

Product Type Insights:

Indication Insights:

Age Group Insights:

End User Insights:

Regional Insights:

Competitive Landscape:

Key Questions Answered in This Report:

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Interventional Cardiology and Peripheral Vascular Devices Market

6 Market Breakup by Product Type

7 Market Breakup by Indication

8 Market Breakup by Age Group

9 Market Breakup by End User

10 Market Breakup by Region

11 Drivers, Restraints, and Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â